GlassScriptPhysician profile
Elyse Roddy
NPI 1942725213
$1,519.34
in general payments reported to CMS, 2019-2025
8 companies · $567 in 2025
The $567 reported for 2025 was more than what 77% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $446 · 2022: $278 · 2023: $182 · 2024: $45.04 · 2025: $567.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $795.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $794.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $558.09 | 2021-2025 | Aveir |
| Medtronic, INC. | $251.41 | 2025 | Symplicity G3, Linq II |
| Abiomed | $180.24 | 2024-2025 | Impella |
| E.R. Squibb & Sons, L.L.C. | $121.42 | 2021 | |
| Amgen INC. | $120.29 | 2023 | Repatha |
| Astrazeneca Pharmaceuticals LP | $118.15 | 2023-2025 | Andexxa, Wainua |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $98.65 | 2025 | Lifevest |
| Impulse Dynamics (USA) INC. | $71.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elyse Roddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.